These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34200312)

  • 1. Medication for Opioid Use Disorder Service Provision and Telephone Counseling: A Concurrent Mixed-Methods Approach.
    Martin R; Kang AW; DeBritz AA; Walton MR; Hoadley A; DelaCuesta C; Hurley L
    Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34200312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Experiences with the Transition to Telephone Counseling during the COVID-19 Pandemic.
    Kang AW; Walton M; Hoadley A; DelaCuesta C; Hurley L; Martin R
    Healthcare (Basel); 2021 Jun; 9(6):. PubMed ID: 34199582
    [No Abstract]   [Full Text] [Related]  

  • 3. Barriers and poor telephone counseling experiences among patients receiving medication for opioid use disorders.
    Kang AW; DeBritz AA; Hoadley A; DelaCuesta C; Walton M; Hurley L; Martin R
    Patient Educ Couns; 2022 Jul; 105(7):2607-2610. PubMed ID: 35279358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical genetic counselor experience in the adoption of telehealth in the United States and Canada during the COVID-19 pandemic.
    Ma D; Ahimaz PR; Mirocha JM; Cook L; Giordano JL; Mohan P; Cohen SA
    J Genet Couns; 2021 Oct; 30(5):1214-1223. PubMed ID: 34757671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives.
    Aronowitz SV; Engel-Rebitzer E; Dolan A; Oyekanmi K; Mandell D; Meisel Z; South E; Lowenstein M
    Harm Reduct J; 2021 Nov; 18(1):119. PubMed ID: 34823538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Counselors' Experiences and Interest in Telegenetics and Remote Counseling.
    Zierhut HA; MacFarlane IM; Ahmed Z; Davies J
    J Genet Couns; 2018 Apr; 27(2):329-338. PubMed ID: 29362948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the reported use of practice-based competencies by North American genetic counselors during the COVID-19 pandemic.
    Wagner NE; Witherington S; Waldman L; Ryan L; Hardy MW
    J Genet Couns; 2021 Oct; 30(5):1257-1268. PubMed ID: 34523197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey.
    Saloner B; Krawczyk N; Solomon K; Allen ST; Morris M; Haney K; Sherman SG
    Int J Drug Policy; 2022 Mar; 101():103537. PubMed ID: 34871945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Telehealth for Opioid Use Disorder Treatment in Safety Net Primary Care Settings: A Mixed-Methods Study.
    Bailey SR; Wyte-Lake T; Lucas JA; Williams S; Cantone RE; Garvey BT; Hallock-Koppelman L; Angier H; Cohen DJ
    Subst Use Misuse; 2023; 58(9):1143-1151. PubMed ID: 37170596
    [No Abstract]   [Full Text] [Related]  

  • 10. A qualitative investigation of addiction counselors' perceptions and experiences implementing an open-access model for treating opioid use disorder.
    Oberleitner LMS; Madden LM; Muthulingam D; Marcus R; Oberleitner DE; Beitel M; Gaeta M; Tamberelli JF; Barry DT
    J Subst Abuse Treat; 2021 Feb; 121():108191. PubMed ID: 33357602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.
    Mehtani NJ; Ristau JT; Snyder H; Surlyn C; Eveland J; Smith-Bernardin S; Knight KR
    Subst Abus; 2021; 42(2):205-212. PubMed ID: 33684331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telemedicine for contraceptive counseling: Patient experiences during the early phase of the COVID-19 pandemic in New York City.
    Stifani BM; Smith A; Avila K; Boos EW; Ng J; Levi EE; Benfield NC
    Contraception; 2021 Sep; 104(3):254-261. PubMed ID: 33861981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the Genetic Counselor SARS-CoV-2 Impact Survey from the National Society of Genetic Counselors: Progress and penalty during the COVID-19 pandemic.
    Pan V; Doerr M; Hoell C; Ryan L; Erwin DJ; Hooker G; Haverty C;
    J Genet Couns; 2021 Aug; 30(4):989-998. PubMed ID: 34308554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The COVID-19 pandemic and opioid use disorder: Expanding treatment with buprenorphine, and combining safety precautions with telehealth.
    Cales RH; Cales SC; Shreffler J; Huecker MR
    J Subst Abuse Treat; 2022 Feb; 133():108543. PubMed ID: 34210567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evidence-based practice guideline of the National Society of Genetic Counselors for telehealth genetic counseling.
    Green S; Hartzfeld D; Terry AB; Fissell K; Friedman S; Paolino N; Principe K; Sandbach J; Trzupek K; Winheld S; Malinowski J
    J Genet Couns; 2023 Feb; 32(1):4-17. PubMed ID: 36054686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review.
    Krawczyk N; Fawole A; Yang J; Tofighi B
    Addict Sci Clin Pract; 2021 Nov; 16(1):68. PubMed ID: 34774106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telehealth in Genetics: The Genetic Counselor Perspective on the Utility of Telehealth in Response to the COVID-19 Pandemic in Wisconsin.
    Choi SH; Salamin MN; Reiser CA; Rachow LE; Lasarev MR; Meyn S; Petty EM
    WMJ; 2022 Apr; 121(1):41-47. PubMed ID: 35442578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiating Opioid Use Disorder Medication via Telemedicine During COVID-19: Implications for Proposed Reforms to the Ryan Haight Act.
    Huskamp HA; Riedel L; Uscher-Pines L; Busch AB; Barnett ML; Raja P; Mehrotra A
    J Gen Intern Med; 2022 Jan; 37(1):162-167. PubMed ID: 34713386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic counselor experiences with telehealth before and after COVID-19.
    Mills R; MacFarlane IM; Caleshu C; Ringler MA; Zierhut HA
    J Genet Couns; 2021 Aug; 30(4):999-1009. PubMed ID: 34231953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic.
    Frost MC; Zhang L; Kim HM; Lin LA
    JAMA Netw Open; 2022 Oct; 5(10):e2236298. PubMed ID: 36223118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.